Targeting Glutamine Metabolism with a Novel Na+/K+-ATPase Inhibitor RX108 in Hepatocellular Carcinoma.
Article in Molecular Cancer Therapeutics (February 2023)
The most recent citing publications are shown below. View all 3 publications that cite this research output on Dimensions.
Article in Molecular Cancer Therapeutics (February 2023)
Article in Frontiers in Pharmacology (January 2023)
Article in Frontiers in Pharmacology (October 2022)